New Galveston Center Gets Its First Director

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 9
Volume 4
Issue 9

GALVESTON, Tex--W. Stratford May, Jr., MD, PhD, has been appointed the first director of the Sealy Center for Oncology and Hematology at the University of Texas Medical Branch at Galveston. He was also named the Bill and Louise Bauer Distinguished Professor in Cancer Research and director of the Division of Hematology/Oncology in the Department of Internal Medicine.

GALVESTON, Tex--W. Stratford May, Jr., MD, PhD, has been appointedthe first director of the Sealy Center for Oncology and Hematologyat the University of Texas Medical Branch at Galveston. He wasalso named the Bill and Louise Bauer Distinguished Professor inCancer Research and director of the Division of Hematology/Oncologyin the Department of Internal Medicine.

Dr. May will be responsible for carrying out the center's goalsto discover new therapies and promote research. The center willinitially have nine principal investigators, each with his orher own lab. Already recruited are Dr. Lei Xiao, who is researchinghow a gene is turned on and off inside a specific cell; Dr. BrianDavis, who is studying viral vectors for gene therapy; and Dr.Takahiko Ito, who is working on signal transduction.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content